Rubicon Advisors
Campaign Finance
$23,250 Given
Information
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
covers through 2011
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$1,201,500 Income
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
covers through Q3, 2011
Lobbying Carried Out by Rubicon Advisors
-
Names of Lobbyists
-
Client Amount Teva Pharmaceuticals USA $315,000 Watson Pharmaceuticals $294,000 Gilead Sciences $225,000 Boehringer Ingelheim Corp $90,000 Office of the Governor of Nathan Deal $87,500 Children's Hospital/Research Ctr Oakland $75,000 Osmotica Pharmaceuticals $70,000 Insmed $45,000 -
Most Frequently Disclosed Lobbying Issues
- Pharmacy,
- Medicare & Medicaid
-
Most Frequently Disclosed Bills
Bill No. Title S.2029 H.R.5629 Oil Spill Accountability and Environmental Protection Act of 2010 H.R.6114 Virgin Islands National Park Land Acquisition Act of 2010